I. Olivetti

Other than growth hormone neuroendocrine actions of ghrelin.

E. Ghigo, F. Broglio, A. Benso, 2013, Endocrine development.

Circulating obestatin levels in normal and Type 2 diabetic subjects

E. Ghigo, D. St-Pierre, F. Broglio, 2010, Journal of endocrinological investigation.

Beta‐adrenergic agonism does not impair the GH response to acylated ghrelin in humans

E. Ghigo, F. Riganti, F. Broglio, 2009, Clinical endocrinology.

The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase.

E. Ghigo, F. Broglio, S. Frara, 2013, European journal of endocrinology.

The metabolic response to the activation of the β- adrenergic receptor by salbutamol is amplified by acylated ghrelin

D. St-Pierre, F. Broglio, F. Prodam, 2010, Journal of endocrinological investigation.

Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans

E. Ghigo, D. St-Pierre, F. Broglio, 2015, Endocrine.

Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects

E. Ghigo, F. Broglio, A. Benso, 2014, Journal of Endocrinological Investigation.

Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans

E. Ghigo, D. St-Pierre, F. Broglio, 2015, Endocrine.